Extracellular regulation of interleukin (IL)-1β through lung epithelial cells and defective IL-1 type II receptor expression

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 5, 1999, Pages 964-975

  Coulter, Kristin R ^a   Wewers, Mark D ^a   Lowe, Melissa P ^a   Knoell, Daren L ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 8; MESSENGER RNA; PRIMER DNA;

ARTICLE; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENETICS; HUMAN; LUNG; METABOLISM; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; LUNG; RECEPTORS, INTERLEUKIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033126398     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.5.3458     Document Type: Article

References (46)

1. Dinarello, C. A. 1996. Biologic basis for interleukin-I in disease. Blood 87: 2095-2147.
2. Duff, G. W., and E. Atkins. 1982. The detection of endotoxin by in vitro production of endogenous pyrogen: comparison with Limilus amebocyte lysate gelatin. J. Immunol. Methods 52:323-331.
3. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch, G. B. Toews, J. Westwick, and R. M. Strieter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
4. Standiford, T. J., S. L. Kunkel, S. H. Phan, B. J. Rollins, and R. M. Strieter. 1991. Alveolar macrophage derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J. Biol. Chem. 266:9912-9918.
5. Levine, S. J. 1995. Bronchial epithelial cell-cytokinc interactions in airway inflammation. J. Investig. Med. 43:241-249.
6. Cromwell, O., Q. Hamid, C. J. Corrigan, J. Barkans, Q. Meng, P. D. Collins, and A. B. Kay. 1992. Expression and generation of interleukin-8, interleukin-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1β and tumor necrosis factor α. Immunology 77:330-337.
7. Antoniades, J. N., J. Neville-Golden, T. Galanopoulos, R. L. Kradin, A. J. Valente, and D. T. Graves. 1992. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 89:5371-5375.
8. Cox, G., J. Gauldie, and M. Jordana. 1992. Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro. Am J. Respir. Cell Mol. Biol. 7:507-513.
9. Xing, Z., T. Ohtoshi, P. Ralph, J. Gauldie, and M. Jordana. 1992. Human upper airway structural cell-derived cytokines support human peripheral blood monocyte survival: a potential mechanism for monocyte/macrophage accumulation in the tissue. Am. J. Respir. Cell Mol. Biol. 6:212-218.
10. Cox, G., T. Ohtoshi, C. Vancheri, J. A. Denburg, J. Dolovich, J. Gauldie, and M. Jordana. 1991. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am. J. Respir. Cell Mol. Biol. 4:525-531.
11. Arend, W. P. 1993. Interleukin-1 receptor antagonist. Adv. Immunol. 54: 167-227.
12. Levine, S. J., T. Benfield, and J. H. Shelhamer. 1996. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line. Am. J. Respir. Cell Mol. Biol. 15:245-251.
13. Levine, S. J., T. Wu, and J. H. Shelhamer. 1997. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells. J. Immunol. 158:5949-5957.
14. McMahan, C. J., J. L. Slack, B. Mosley, D. Cosman, S. D. Lupton, L. L. Brunton, C. E. Grubin, J. M. Wignall, N. A. Jenkins, C. I. Brannan, N. G. Copeland, K. Huebner, C. M. Croce, L. A. Cannizzarro, D. Benjamin, S. K. Dower, M. K. Spriggs, and J. E. Sims. 1991. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10:2821-2832.
15. Liu, C., R. P. Hart, X.-J. Liu, W. Clevenger, R. A. Maki, and E. B. DeSouza. 1996. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA. J. Biol. Chem. 271:20965-20972.
16. Sims, J. E., J. G. Giri, and S. K. Dower. 1994. The two interleukin-1 receptors play different roles in IL-1 actions. Clin. Immunol. Immunopathol. 72:9-14.
17. Greenfeder, S. A., P. Nunes, L. Kwee, M. Labow, R. A. Chizzonite, and G. Ju. 1995. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270:13757-13765.
18. Wesche, J., D. Neumann, K. Resch, and M. U. Martin. 1996. Co-expression of mRNA for type I and type II interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsiveness. FEBS Lett. 391: 104-108.
19. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giri, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4 Science 261: 472-475.
20. Colotta, F., S. Saccani, J. G. Giri, S. K. Dower, J. E. Sims, M. Introna, and A. Mantovani. 1996. Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J. Immunol. 156: 2534-2541.
21. Orlando, S., M. Sironi, G. Bianchi, A. H. Drummond, D. Boraschi, D. Tabes, and A. Mantovani. 1997. Role of metalloproteases in the release of the IL-1 type II decoy receptor. J. Biol. Chem. 272:31764-31769.
22. Re, F., M. Muzio, M. DeRossi, N. Polentarutti, J. G. Giri, A. Mantovani, and F. Colotta. 1994. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J. Exp. Med. 179:739-743.
23. Slack, J., C. J. McMahan, S. Waugh, K. Schooley, M. K. Spriggs, J. B. Sims, and S. K. Dower. 1993. Independent binding of interleukin-1α and interleukin-1β to type I and type II interleukin-1 receptors. J. Biol. Chem. 268: 2513-2524.
24. Symons, J. A., P. A. Young, and G. W. Duff. 1994. Differential release and ligand binding of type II IL-1 receptors. Cytokine 6:555. (Abstr.)
25. Giri, J. G., J. Wells, S. K. Dower, C. E. McCall, R. N. Guzman, J. Slack, T. A. Bird, K. Shanebeck, K. H. Grabstein, J. E. Sims, and M. R. Alderson. 1994. Elevated levels of shed type II IL-1 receptor in sepsis, potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153: 5802-5809.
26. Arend, W. P., M. Malyak, M. F. Smith, Jr., T. D. Whisenand, J. L. Slack, J. E. Sims, J. G. Giri, and S. K. Dower. 1994. Binding of IL-1α, IL-1β, and IL 1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL 1 receptors in synovial fluids. J. Immunol. 153:4766-4774.
27. Allen, J. N., Z. Liao, M. D. Wewers, B. A. Altenberger, S. A. Moore, and E. D. Allen. 1996. Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia. J. Allergy Clin. Immunol. 97:1366-1374.
28. Huang, J., X. Gao, S. Li, and Z. Cao. 1997. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl. Acad. Sci. USA 94:12829-12832.
29. Wesche, H., C. Korherr, M. Kracht, W. Falk, K. Resch, and M. U. Martin. 1997. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1 induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272:7727-7731.
30. Mattoli, S., F. Colotta, G. Fincato, M. Mezzetti, A. Mantovani, F. Patalano, and A. Fasoli. 1991. Time course of IL-1 and IL-6 synthesis and release in human bronchial epithelial cell cultures exposed to toluene diisocyanate. J. Cell. Physiol. 149:260-268.
31. Devalia, J. L., A. M. Campbell, R. J. Sapsford, C. Rusznak, D. Quint, P. Godard, J. Bousquet, and R. J. Davies. I993. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am. J. Respir. Cell Mol. Biol. 9:271-278.
32. Groves, R. W., J. Giri, J. Sims, S. K. Dower, and T. S. Kupper. 1995. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. J. Immunol. 154:4065-4072.
33. McGee, D. W., S. J. Vitkus, and P. Lee. 1996. The effect cytokine stimulation on IL-1 receptor mRNA expression by intestinal epithelial cells. Cell. Immunol. 168:276-280.
34. Lieber, M., B. Smith, A. Szakal, W. Nelson-Rees, and G. Todaro. 1976. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 17:62-70.
35. Marsh, C. B., J. E. Gadek, G. C. Kindt, S. A. Moore, and M. D. Wewers. 1995. Monocyte Fe gamma receptor cross-linking induces IL-8 production. J. Immunol. 155:3161-3167.
36. Altenberger, E. A., H. A. Pope, and M. D. Wewers. 1995. Detection of soluble type II receptor in the presence of its natural ligand IL-1 beta. Quantification by sandwich ELISA. J. Immunol. Methods 185:115-122.
37. Marsh, C. B., and M. D. Wewers. 1994. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes. Am. J. Respir. Cell Mol. Biol. 10:521-525.
38. Chomezynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
39. Orlando, S., M. Sironi, G. Bianchi, A. H. Drummond, D. Boraschi, D. Yabes, and A. Mantovani. 1997. Role of metalloproteases in the release of the IL-1 type II decoy receptor. J. Biol. Chem. 272:31764-31769.
40. Brown, E. A., H. A. Dare, C. B. Marsh, and M. D. Wewers. 1996. The combination of endotoxin and dexamethasone induces type II interleukin-1 receptor (IL-1r II) in monocytes: a comparison to interleukin-1β (IL-1β) and interleukin-1 receptor antagonist (IL-1ra). Cytokine 8:828-836.
41. Giri, J. G., R. Robb, W. L. Wong, and R. Horuk. 1992. HepG2 cells predominantly express the type II interluekin-1 receptor (biochemical and molecular characterization of the IL-1 receptor). Cytokine 4:18-23.
42. Mancilla, J., I. Ikejima, and C. A. Dinarello. 1992. Glycosylation of the interleukin-1 receptor type 1 is required for optimal binding of interleukin-1. Lymphokine Cytokine Res. 11:197-205.
43. Re, F., M. Sironi, M. Muzio, C. Matteucci, M. Introna, S. Orlando, G. Penton-Rol, S. K. Dower, J. E. Sims, F. Colotta, and A. Mantovani. 1996. Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function. J. Exp. Med. 183:1841-1850.
44. Burger, D., R. Chicheportiche, J. G. Giri, and J. M. Dayer. 1995. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J. Clin. Invest. 96:38-41.
45. Preas, H. L., D. Reda, M. Tropea, R. W. Vandivier, S. M. Banks, J. M. Agosti, and A. F. Suffredini. 1996. Effects of recombinant soluble type I interleukin-1 receptor on human inflammatory responses to endotoxin. Blood 88:2465-2472.
46. Shanley, T. P., J. L. Peters, M. L. Jones, S. W. Chensue, S. L., Kunkel, and P. A. Ward. 1996. Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury. J. Clin. Invest. 97:963-970.